INSIGHTS ON UPSTREAM MANUFACTURING
-
The Bispecific Antibody Boom Has A Manufacturing Fix
Advanced cell line strategies improve stability and chain pairing while accelerating production, helping developers overcome scalability, productivity, and timeline challenges.
-
DynaDrive S.U.B. Video Series
Explore DynaDrive Single-Use Bioreactors through expert videos covering reactor design, mixing performance, sparge technology, and scalable workflows from bench-scale to commercial production.
-
Scale-Up Of AAV Production In Fixed-Bed Bioreactors
Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.
-
Cost Modeling Analysis Of AAV And LV Manufacturing
Manufacturing scale plays a critical role in viral vector economics. Compare AAV and LV production scenarios to gain insight into how intermediate-scale strategies can reduce cost and risk.
-
DynaDrive Single-Use Bioreactors Drilled-Hole Sparge Technology3/30/2026
Uniform bubble size and consistent mass transfer across scales through drilled-hole sparge technology improves oxygen delivery and CO2 stripping in demanding cell culture processes.
-
DynaDrive Single-Use Bioreactors - One Reactor, Many Volumes3/30/2026
Single-use bioreactors with turndown ratios up to 20:1 enable facilities to operate across wide volume ranges within the same vessel, streamlining seed trains and reducing capital requirements for multi-product operations.
-
Scale With Confidence From Bench To Commercial Production3/30/2026
Consistent vessel design, sparging, and bag materials across 1L to 5,000L volumes enable predictable bioreactor scale-up from development through commercial manufacturing.
-
Why Is The Bioreactor Square? The Geometry Behind Exceptional Mixing3/30/2026
Cuboid bioreactor design eliminates vortexing through natural baffling, delivering homogeneous mixing and consistent nutrient distribution for high cell density upstream processes.
UPSTREAM MANUFACTURING SOLUTIONS
-
Learn how xeno-free human dermal fibroblasts achieve over 1 billion cells in 10 days through optimized 2D and 3D expansion protocols designed for clinical-scale therapeutic manufacturing applications.
-
A concentrated bioreactor feed, RoosterReplenish-MSC-XF & prcRoosterReplenish-MSC-CC enable a fed-batch process for scalable, translation-ready cGMP hMSC manufacturing.
-
Reliable sample protection comes from secure facilities. Learn how multiple storage formats, split‑site options, and full audit trails help ensure biological materials remain ready for future use.
-
Look at how optimized virus banking strengthens manufacturing by enhancing consistency, speeding characterization timelines, and aligning testing strategies with modern regulatory expectations.
-
Reliable cell banks are essential for protecting research quality. See how expert support and structured processes help maintain cell line integrity, reduce risk, and strengthen development.